Lynsey C. Priest
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung Cancer.
Journal: bioRxiv : the preprint server for biology
Published: February 26, 2024
A TIAM1-TRIM28 complex mediates epigenetic silencing of protocadherins to promote migration of lung cancer cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 25, 2023
Measurement of changes in uterine and fibroid volume during treatment of heavy menstrual bleeding (HMB).
Journal: Human reproduction open
Published: November 21, 2022
Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic Mimicry.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 12, 2022
cfDNA methylome profiling for detection and subtyping of small cell lung cancers.
Journal: Nature cancer
Published: January 31, 2022
EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer.
Journal: Translational lung cancer research
Published: May 20, 2021
Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer.
Journal: Nature communications
Published: December 10, 2020
The Rare YAP1 Subtype of SCLC Revisited in a Biobank of 39 Circulating Tumor Cell Patient Derived Explant Models: A Brief Report.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 04, 2020
Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 01, 2019
Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 26, 2019
Last Updated: 09/26/2026